Addressing the Barriers to Pediatric Drug Development: Workshop Summary
2008

Workshop

You must be logged in to download this publication.

Select Book Type

Paperback - $26.10
Ebook - $21.59

Request an exam or desk copy

Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children—50 to 75 percent—have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.

Publication information

64 pages · 6 x 9 · paperback
ISBN Paperback: 0-309-10742-3
ISBN Ebook: 0-309-10743-1
DOI: https://doi.org/10.17226/11911

Suggested citation

Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press.

Import this citation to:

Bibtext
EndNote
Reference manager

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

Search this publication

Front Matter i-xii
Summary 1-6
1 Introduction 7-9
2 Regulatory Framework 10-19
3 Current Challenges in Developing and Prescribing Drugs for Children 20-28
4 Models for Enhancing Pediatric Drug Development 29-35
5 Challenges and Opportunities for the Future 36-40
References 41-42
Appendix A: Workshop Agenda 43-45
Appendix B: Speaker Biographies 46-52

Log In

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Email (required)

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Addressing the Barriers to Pediatric Drug Development: Workshop Summary (2008)

Chapter: 1 Introduction

Publication information

Suggested citation

My Academies

Addressing the Barriers to Pediatric Drug Development: Workshop Summary (2008)

Chapter: 1 Introduction